Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373

FIasp® vs. Novolog® in Type 1 Diabetics Using 670G Medtronic Pump

FIasp® vs. Novolog® in Type 1 Diabetics Using 670G Medtronic Pump

Condition:   Type 1 Diabetes Mellitus
Interventions:   Drug: Fiasp®;   Drug: Novolog®;   Device: 670G hybrid closed loop continuous subcutaneous insulin infusion system
Sponsor:   Texas Diabetes & Endocrinology, P.A.
Recruiting
ClinicalTrials.gov: Endocrinology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 6, 2019 / by / in
Comments